Prognostic utility of MELD-XI in adult congenital heart disease patients undergoing cardiac transplantation.


BACKGROUND Model of End-Stage Liver Disease eXcluding INR (MELD-XI) at cardiac transplant has demonstrated prognostic survival utility, but has not been specifically validated in adult congenital heart disease (ACHD) in a registry study. METHODS Adults undergoing first-time orthotopic heart transplant from 2005 to 2015 in the United Network for Organ… (More)
DOI: 10.1111/ctr.13257


  • Presentations referencing similar topics